Andere Sprachen DMK Pharmaceuticals Corporation

Aktien

A3EEVQ

US00547W3079

DMKPQ

Markt geschlossen - OTC Markets Andere Börsenplätze 21:52:21 03.05.2024			% 5 Tage	% 1. Jan.
0.05 ^USD	+50.15%		+42.86%	-92.86%

06.02.	Antrag auf gemeinsame Verwaltung für DMK Pharmaceuticals Corporation genehmigt	CI
02.02.	Antrag auf gemeinsame Verwaltung durch DMK Pharmaceuticals Corporation eingereicht	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	11.04.
North American Morning Briefing : Focus Turns to -2-	04.04.
Bidding Procedure Approved for DMK Pharmaceuticals Corporation	04.04.
Motion for Asset Sale Filed by DMK Pharmaceuticals Corporation	21.03.
DMK Pharmaceuticals Corporation(NasdaqCM:DMK) dropped from S&P TMI Index	08.02.
Motion for Joint Administration Approved for DMK Pharmaceuticals Corporation	06.02.
DMK Pharmaceuticals Corporation(OTCPK:DMKP.Q) dropped from NASDAQ Composite Index	06.02.
DMK Pharmaceuticals Commences Restructuring Proceeding	03.02.
Motion for Joint Administration Filed by DMK Pharmaceuticals Corporation	02.02.
DMK Pharmaceuticals Corporation Filed for Bankruptcy	02.02.
DMK Pharmaceuticals Corporation Announces Board Appointments	31.01.
DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI	21.12.
DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate Update	28.11.
DMK Pharmaceuticals Corporation Regains Full Rights from US WorldMeds for SYMJEPI	28.11.
DMK Pharmaceuticals Corporation(OTCPK:DMKP.Q) added to NASDAQ Composite Index	21.11.
Adamis Pharmaceuticals Corporation(NasdaqCM:ADMP) dropped from NASDAQ Composite Index	20.11.
DMK Pharmaceuticals: Q3 Earnings Snapshot	14.11.
Earnings Flash (DMK) DMK PHARMACEUTICALS CORPORATION Reports Q3 Revenue $9,062	14.11.
DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update	14.11.
DMK Pharmaceuticals Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen DMK Pharmaceuticals Corporation

Aktien

A3EEVQ

US00547W3079

DMKPQ

Andere Sprachen

Filter